针对SARS-CoV-2尖端蛋白的免疫表位和对通用疫苗开发的考虑
Nicholas Magazine1, Tianyi Zhang1, Anang D Bungwon1
1Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA.
ImmunoHorizons
|March 1, 2024
概括
新的SARS-CoV-2变种通过逃避免疫来挑战COVID-19疫苗. 识别Spike蛋白质上的保存表位对开发下一代针对新兴突变的疫苗至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 全球COVID-19疫苗接种工作面临新的SARS-CoV-2菌株的挑战,这些菌株表现出免疫逃避.
- 作为疫苗的关键标,SARS-CoV-2尖端蛋白也是一个突变热点,有助于免疫逃脱和改变宿主易感性.
- 预测病毒突变和识别保存表位是创造广泛中和疗法和通用疫苗的必要条件.
研究的目的:
- 审查对COVID-19疫苗的免疫反应.
- 确定与保护性免疫相关的SARS-CoV-2尖端蛋白的关键免疫表位.
- 分析通过TLRs,B细胞和T细胞影响免疫激活的Spike蛋白的结构和进化特征.
主要方法:
- 关于对COVID-19疫苗免疫反应的文献综述.
- 对SARS-CoV-2尖刺蛋白的结构和进化特征的分析.
- 检查涉及TLRs,B细胞和T细胞的免疫激活通路.
主要成果:
- 斯派克蛋白的突变部位对于SARS-CoV-2的免疫逃避至关重要.
- 在Spike蛋白质上保存的表位对引起保护性免疫至关重要.
- 了解Spike蛋白结构-功能关系有助于预测免疫反应.
结论:
- 开发通用COVID-19疫苗需要对尖端蛋白表位和病毒演变有深入的了解.
- 准保存的表位物可以克服新出现的SARS-CoV-2变种所带来的挑战.
- 这一分析为设计具有广泛中和能力的下一代疫苗提供了洞察力.
更多相关视频
12:09Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
42.8K
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
3.6K
相关概念视频
Conjugated Proteins
18.3K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.3K
Cross-reactivity
31.1K
Overview
31.1K
Antigens Involved in Adaptive Immunity
491
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
491
